Literature DB >> 31264307

Risk-reducing surgery in BRCA1/BRCA2 mutation carriers: Are there factors associated with the choice?

Siranoush Manoukian1, Sara Alfieri2, Elisabetta Bianchi2, Bernard Peissel1, Jacopo Azzollini1, Claudia Borreani2.   

Abstract

OBJECTIVE: Female carriers of BRCA1/BRCA2 mutations (BRCAm) are at increased risk of developing breast and ovarian cancer. The main prevention options currently available consist in either clinical-radiological surveillance or risk-reducing surgery. This study investigated factors that might influence the choice of risk-reducing mastectomy (RRM) and/or salpingo-oophorectomy (RRSO) over surveillance in high-risk women.
METHODS: One hundred twenty-eight BRCAm women, 75 (58.60%) cancer affected (C-A) and 53 (41.40%) cancer-unaffected (C-UN), completed a baseline questionnaire concerning socio-demographic factors, personal medical history, cancer family history, and psychological dimensions. Preferences about prevention strategies were evaluated after 15 months. Multivariate logistic regression was used to analyse the relationship between these factors and the choice of RRSO or RRM in the whole cohort and the choice of surgery (RRM and/or RRSO) in C-A and C-UN women.
RESULTS: The analyses on the whole cohort highlighted factors associated with the choice of both RRM and RRSO ("cancer concern," "previous therapeutic mastectomy," and "number of cancer-affected family members"), but also a few specifically associated with either RRM (age) or RRSO ("health" and "energy" perception and "number of children"). Surgery was more likely to be chosen by C-A (76%) than C-UN women (34%). With the exception of "cancer concern," factors associated with the choice of surgery were different between C-A ("number of deaths for cancer in the family" and "feeling downhearted and blue") and C-UN ("number of children" and "health perception") women.
CONCLUSION: This study highlights potential drivers underlying the choice of preventive surgery, which should be considered when supporting the decision-making process in these women.
© 2019 John Wiley & Sons, Ltd.

Entities:  

Keywords:  cancer; decision making; genetic counselling; high-risk women; mastectomy; oncology; oophorectomy; prophylactic surgery; surveillance

Mesh:

Substances:

Year:  2019        PMID: 31264307     DOI: 10.1002/pon.5166

Source DB:  PubMed          Journal:  Psychooncology        ISSN: 1057-9249            Impact factor:   3.894


  4 in total

1.  Time trends in uptake rates of risk-reducing mastectomy in Israeli asymptomatic BRCA1 and BRCA2 mutation carriers.

Authors:  Lee Galmor; Rinat Bernstein-Molho; Miri Sklair-Levy; Dana Madoursky-Feldman; Dov Zippel; Yael Laitman; Eitan Friedman
Journal:  Breast Cancer Res Treat       Date:  2020-09-30       Impact factor: 4.872

2.  Formulation of an ovarian cancer vaccine with the squalene-based AddaVax adjuvant inhibits the growth of murine epithelial ovarian carcinomas.

Authors:  Suparna Mazumder; Valerie Swank; Nina Dvorina; Justin M Johnson; Vincent K Tuohy
Journal:  Clin Exp Vaccine Res       Date:  2022-05-31

3.  Barriers and facilitators to CDH1 carriers contemplating or undergoing prophylactic total gastrectomy.

Authors:  Kaitlin M McGarragle; Tae L Hart; Carol Swallow; Savtaj Brar; Anand Govindarajan; Zane Cohen; Melyssa Aronson
Journal:  Fam Cancer       Date:  2020-08-05       Impact factor: 2.375

4.  Physician attitudes and knowledge on prophylactic salpingectomy in perimenopausal patients.

Authors:  Michael Fialkow; Neko Castleberry; Jason D Wright; Jay Schulkin; Vrunda B Desai
Journal:  Gynecol Oncol Rep       Date:  2021-06-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.